BioSpace News Archive

Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announces new data confirming that in-person assessments may not fully capture at-home hand tremor fluctuations for patients with essential tremor (ET)

GBS, Inc. (NasdaqGS: GBS), a life sciences company developing non-invasive, real-time point-of-care (POC) diagnostic tests, and the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Institute) have received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a validation study to test clinical samples from a COVID-19 repository.

Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A.

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today publication of research, titled, “Generation of recombinant hyperimmune globulins from diverse B cell repertoires,” in the peer-reviewed journal Nature Biotechnology.

The American College of Physicians, publisher of Annals of Internal Medicine, one of the most influential peer-reviewed clinical journals in the world, and the American Heart Association announce a new partnership to jointly publish Annals of Internal Medicine: Clinical Cases.

MJH Life Sciences™ is proud to announce an official partnership with the International Society for Vaccines (ISV) by adding them to its Strategic Alliance Partnership (SAP) program

The Government of Canada is working with all partners to protect the health and safety of Canadians and to reduce the spread of COVID-19 and the variants of concern in Canada.

American Bio Medica Corporation announced financial results for the fourth quarter and year ended December 31, 2020.

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that its Audit Committee will meet the week of April 19 to review and approve the filing of the company’s 2020 Annual Report on Form 10-K and related earnings release.

Pfizer Inc. (NYSE: PFE) announced today that shareholders and the general public are invited to access its virtual-only 2021 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 22, 2021